Key result
Administration of promethazine and intramuscular ziprasidone in a post-liver transplant patient triggered atypical neuroleptic malignant syndrome without elevated creatine kinase.
Population
1 patient with significant risk factors who developed atypical NMS 6 days after a liver transplant
Design
Case_report
Authors
Loading...
Atypical NMS without CK elevation warrants vigilance in post-transplant patients on these agents; single case leaves open generalizability.
Case Report (n=1)
Highlights the importance of rapid diagnosis and management of atypical NMS presenting without elevated creatine kinase.
Schreiner et al. (2017) conducted a case report in Atypical Neuroleptic Malignant Syndrome (n=1). Promethazine and ziprasidone was evaluated on Development of atypical NMS and recovery. Administration of promethazine and intramuscular ziprasidone in a post-liver transplant patient triggered atypical neuroleptic malignant syndrome without elevated creatine kinase.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: